These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35674309)

  • 21. A nationwide survey on unilateral moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow-augmentation bypass for moyamoya disease.
    Fujimura M; Tominaga T
    J Neurosurg Sci; 2021 Jun; 65(3):277-286. PubMed ID: 33245218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease.
    Takagi Y; Kikuta K; Sadamasa N; Nozaki K; Hashimoto N
    Neurosurgery; 2006 Oct; 59(4):894-900; discussion 900-1. PubMed ID: 17038954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insufficient production of IL-10 from M2 macrophages impairs in vitro endothelial progenitor cell differentiation in patients with Moyamoya disease.
    Nagata E; Masuda H; Nakayama T; Netsu S; Yuzawa H; Fujii N; Kohara S; Sorimachi T; Osada T; Imazeki R; Matsumae M; Asahara T; Takizawa S
    Sci Rep; 2019 Nov; 9(1):16752. PubMed ID: 31727941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease.
    Matsuo M; Nadanaka S; Soga M; Sugiyama T; Serigano S; Shimano K; Ichinose F; Nakamura T; Maeda T; Houkin K; Era T; Kitagawa H
    Sci Rep; 2021 Jan; 11(1):1552. PubMed ID: 33452387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.
    Hamauchi S; Shichinohe H; Uchino H; Yamaguchi S; Nakayama N; Kazumata K; Osanai T; Abumiya T; Houkin K; Era T
    PLoS One; 2016; 11(9):e0163561. PubMed ID: 27662211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
    Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior Circulation Moyamoya Disease versus Primitive Vertebral-Basilar Artery System Moyamoya Disease: New Classification of Moyamoya Disease from the Perspective of Embryology.
    Tan C; Duan R; Ye X; Zhang D; Wang R
    World Neurosurg; 2016 Dec; 96():222-229. PubMed ID: 27593720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological features of middle cerebral arteries from patients treated for Moyamoya disease.
    Takagi Y; Kikuta K; Nozaki K; Hashimoto N
    Neurol Med Chir (Tokyo); 2007 Jan; 47(1):1-4. PubMed ID: 17245006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo demonstration of blood-brain barrier impairment in Moyamoya disease.
    Narducci A; Yasuyuki K; Onken J; Blecharz K; Vajkoczy P
    Acta Neurochir (Wien); 2019 Feb; 161(2):371-378. PubMed ID: 30675657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease.
    Takagi Y; Kikuta K; Nozaki K; Fujimoto M; Hayashi J; Imamura H; Hashimoto N
    Neurosurgery; 2007 Feb; 60(2):338-45; discussion 345. PubMed ID: 17290185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 33. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.
    Blecharz KG; Frey D; Schenkel T; Prinz V; Bedini G; Krug SM; Czabanka M; Wagner J; Fromm M; Bersano A; Vajkoczy P
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1527-1539. PubMed ID: 27381827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moyamoya Disease.
    Fujimura M; Bang OY; Kim JS
    Front Neurol Neurosci; 2016; 40():204-220. PubMed ID: 27960175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease.
    Liu Y; Huang Y; Zhang X; Ma X; He X; Gan C; Zou X; Wang S; Shu K; Lei T; Zhang H
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Suyama K; Nagata I
    Clin Neurol Neurosurg; 2013 Jul; 115(7):930-3. PubMed ID: 23041378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data-Independent Acquisition-Based Serum Proteomic Profiling of Adult Moyamoya Disease Patients Reveals the Potential Pathogenesis of Vascular Changes.
    Wang Z; Ji C; Han Q; Wang Z; Huang Y
    J Mol Neurosci; 2022 Dec; 72(12):2473-2485. PubMed ID: 36520382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunopathological features of Moyamoya disease.
    Lin R; Xie Z; Zhang J; Xu H; Su H; Tan X; Tian D; Su M
    PLoS One; 2012; 7(4):e36386. PubMed ID: 22558457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.
    Fujimura M; Fujimura T; Kakizaki A; Sato-Maeda M; Niizuma K; Tomata Y; Aiba S; Tominaga T
    Brain Res; 2018 Jan; 1679():39-44. PubMed ID: 29174692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.